Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 19 | 40237979 | missense variant | C/T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.800 | 1.000 | 4 | 2004 | 2013 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
0.800 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
19 | 40236313 | missense variant | T/C | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 2 | 2005 | 2014 | ||||||||||
|
0.851 | 0.080 | 19 | 40235953 | missense variant | C/A;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 2 | 2012 | 2014 | |||||||
|
1.000 | 0.040 | 19 | 40282734 | 5 prime UTR variant | T/C | snv | 0.76 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 19 | 40267017 | intron variant | C/A | snv | 0.18 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 19 | 40250008 | intron variant | C/T | snv | 0.12 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.080 | 19 | 40277326 | intron variant | T/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 19 | 40272959 | intron variant | T/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
19 | 40254542 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2008 | 2008 | ||||||||
|
0.925 | 0.160 | 19 | 40233814 | 3 prime UTR variant | G/T | snv | 0.39 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.160 | 19 | 40233814 | 3 prime UTR variant | G/T | snv | 0.39 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
19 | 40265075 | intron variant | T/C | snv | 0.73 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 0.120 | 19 | 40238790 | intron variant | T/C | snv | 0.24 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.080 | 19 | 40255305 | splice region variant | G/A | snv | 8.4E-02 | 9.7E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.742 | 0.280 | 19 | 40257052 | stop gained | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 |